Ocera Therapeutics Inc Stock

Stocks

17-11-02	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-10-20	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
17-08-23	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
17-08-01	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
17-06-01	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
ELI LILLY AND COMPANY	-1.61%	+1.72%	+38.30%	+106.93%	1,043B
JOHNSON & JOHNSON	-0.76%	-0.84%	+35.21%	+62.70%	618B
ABBVIE INC.	+0.39%	+4.81%	+17.81%	+83.77%	481B
MERCK & CO., INC.	-0.29%	-0.99%	+64.79%	+37.06%	351B
ROCHE HOLDING AG	-2.03%	+1.06%	+21.08%	+42.16%	338B
NOVARTIS AG	-1.92%	-0.29%	+10.54%	+33.20%	269B
ASTRAZENECA PLC	-2.36%	-1.16%	-7.14%	+8.68%	244B
AMGEN INC.	-1.37%	+0.04%	+38.29%	+52.33%	220B
GILEAD SCIENCES, INC.	+0.17%	-0.27%	+24.40%	+96.82%	182B
Average	-0.96%	+0.28%	+27.03%	+58.18%	416.3B
Weighted average by Cap.	-1.04%	+0.60%	+30.46%	+68.88%

Employees

Sector